WHO ICTRP trial

Efficacy of home phototherapy versus inpatient phototherapy for neonatal…

ChiCTR2500110128 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500110128
Public title Efficacy of home phototherapy versus inpatient phototherapy for neonatal hyperbilirubinemia: a randomised controlled trial
Scientific title Efficacy of home phototherapy versus inpatient phototherapy for neonatal hyperbilirubinemia: a randomised controlled trial
Primary sponsor Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Longgang Maternity and Child Institute of Shantou University Medical College)
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Countries China
Conditions Neonatal hyperbilirubinemia
Interventions Home Phototherapy Group:Newborns with hyperbilirubinemia receive phototherapy at home, and team members provide instructions on how to use it, precautions, and nursing.;Inpatient Phototherapy Group:Neonates with hyperbilirubinemia are…
Registration date Sep 30, 2025
Target size Home Phototherapy Group:106;Inpatient Phototherapy Group:106
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations